An article by Roberts and associates (1) was discussed in a Letter to the Editor by Padera and colleagues (2) and a Response from Skobe and Godbold (3). The Letter and Response appeared under a title that was not appropriate for both letters. The correct title for the correspondence should be Anti-VEGFR-3 Therapy and Lymph Node Metastasis.

1
Roberts N, Kloos B, Cassella M, Podgrabinska S, Persaud K, Wu Y, Pytowski B, Skobe M. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2.
Cancer Res
 
2006
;
66
:
2650
–7.
2
Padera TP, Ancukiewicz M, Hoshida T, Fukumura D, Jain RK. Data do not support benefits of anti-VEGFR3 therapy.
Cancer Res
 
2007
;
67
:
5055
.
3
Skobe M, Godbold J. Data do not support benefits of anti-VEGFR3 therapy.
Cancer Res
 
2007
;
67
:
5056
.
View Original Article
©2007 American Association for Cancer Research.
2007